Long Covid Newsletter
Issue #9November 3, 20257 studies

The genetic and microbiome clues about who gets long COVID

The genetic and microbiome clues about who gets long COVID

Monday, November 3rd Long Covid Newsletter Issue #9

This week's research reveals how our microbiome shapes long COVID experiences and shows that even 'mild' cases in children create lasting challenges. Plus, new insights on why some people can't shake persistent symptoms.

🦠 Your Gut Bacteria May Predict Your Long COVID Experience

Scientists analyzed 349 people with long COVID and discovered something fascinating: the bacteria in your mouth and gut correlate with which symptoms you'll experience.

  • They identified three distinct symptom patterns: 21% had severe constitutional symptoms (fatigue, brain fog), 17% primarily lost smell/taste, and 62% had minimal lingering symptoms

  • People with high symptom burden had less diverse gut bacteria, and specific bacterial types linked to nausea and smell/taste problems

  • Interestingly, they found very little evidence of persistent virus in saliva or stool samples, suggesting bacterial imbalance—not viral persistence—drives many long COVID symptoms

Why this matters: This research points toward potential microbiome-targeted treatments for long COVID. If bacterial dysbiosis contributes to symptom severity, restoring healthy gut bacteria could offer a new therapeutic pathway beyond just managing individual symptoms.

🎖️ Top 10% journal 🔗 iScience 🗓️ Oct 27

Key Findings

🧒 Even 'Mild' Long COVID Hits Kids Hard for Years

Researchers followed 68 children with persistent long COVID symptoms for 24 months and found that even kids with fewer symptoms (4-5 vs 6.5-9) experienced lasting anxiety, respiratory problems, and school concerns. The study revealed two symptom groups, but both struggled with long-term impacts on daily life. Most participants were older teens (72.1% aged 15-17) and female (82.4%).

💡 Fewer symptoms doesn't mean less suffering—even 'mild' pediatric long COVID creates significant long-term challenges.
Top 30% journal 🔗 BMJ Paediatrics Open 🗓️ Oct 22

🧬 Genetic Clues Explain Why Some Get Long COVID

Scientists discovered that certain immune system genes (HLA alleles) protect against or predispose people to long COVID, ME/CFS, and post-Lyme disease. The protective genes strongly bind to virus proteins, likely helping eliminate infections, while susceptibility genes bind weakly—potentially allowing pathogens to persist. The same genetic patterns appeared across all three conditions, suggesting shared mechanisms.

💡 Your genetic makeup may determine whether your immune system can fully clear infections or lets them linger.
Top 20% journal 🔗 Scientific Reports 🗓️ Oct 24

📊 How You Ask About Long COVID Changes the Numbers

A Michigan study of 3,826 adults revealed dramatic differences in long COVID prevalence depending on survey timing and wording. At 4.4 months post-infection, 17% reported 90+ day symptoms. But 18 months later, 24.5% said they'd 'ever experienced long COVID' while only 10.8% had medical diagnoses. Among those without early symptoms, 17.3% later reported long COVID—and 31.1% with early symptoms later denied having long COVID.

💡 Long COVID prevalence estimates vary wildly based on how and when you ask—highlighting the need for standardized definitions.
Top 20% journal 🔗 Preventive Medicine Reports 🗓️ Oct 27

🏥 COVID Survivors Use Healthcare Differently Than Other Respiratory Patients

Italian researchers compared 35,458 COVID-19 survivors to 21,375 other respiratory infection survivors over 12 months. COVID patients had delayed but more frequent specialist visits (75.8% vs 70.3%), more imaging and lung function tests, and higher rates of new diabetes (42% increase), psychiatric (21% increase), and hormonal medications. However, they had fewer overall chronic drug prescriptions and hospitalizations.

💡 COVID survivors show distinct healthcare patterns—fewer overall medications but more targeted interventions for specific organ systems.
🎖️ Top 10% journal 🔗 Infectious Diseases and Therapy 🗓️ Oct 27

🇦🇺 1 in 10 Young Australians Report Long COVID

A survey of 765 Australians aged 15-29 found 11.2% reported ever having long COVID, but only 1 in 10 received medical diagnosis. Those with long COVID were younger, had worse general health, worried more about reinfection, and often had family/friends with similar experiences. Among those with current symptoms, 79.1% reported work difficulties and accomplishing less than desired.

💡 Long COVID significantly impacts young adults' work and life, but most cases go undiagnosed by medical professionals.
Top 50% journal 🔗 Public Health Challenges 🗓️ Oct 23

🧓 Age and Breathing Problems Drive Disability in Elderly Long COVID

Brazilian researchers studied 288 elderly long COVID patients using WHO disability assessments and found that being 70+ years old and experiencing shortness of breath were the primary factors increasing disability scores. The study highlights how specific symptoms, rather than just having long COVID generally, determine functional impairment in older adults.

💡 In elderly long COVID patients, respiratory symptoms and advanced age are the key drivers of functional disability.
Top 20% journal 🔗 Geriatric Nursing 🗓️ Oct 22

Implications

This week's research reveals long COVID as a complex, multi-system condition where your microbiome, genetics, age, and specific symptoms all influence outcomes. The findings suggest we need personalized approaches—from microbiome restoration to age-specific care—rather than one-size-fits-all treatments.

Studies in this issue

Primary sources used for this newsletter.

  1. Disability and related factors in older adults with long COVID in a large Brazilian city
    key findingGeriatric nursing (New York, N.Y.)2025-10-22PMID 41124714
  2. How Different Survey Questions Affect Long COVID Rates and Inequality
    key findingPreventive medicine reports2025-10-27PMID 41142667

Continue reading

All Long Covid issues